TNXP
Tonix Pharmaceuticals Holding Corp.Company with tickers: TNXP
CIK
1430306
CUSIP
890260839
Shares Outstanding
15,940,801
13F Activity (30d)
71 filings
69 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $6,878,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Cost of Revenue | $1,578,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $18,213,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Operating Income | $-41,537,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| Net Income | $-40,194,000 | USD | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Basic) | $-2.93 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |
| EPS (Diluted) | $-2.93 | USD/shares | 2026-03-31 | 10-Q | 2026-05-11 |